Changing Epidemiology of Hepatitis C Virus Genotype among Patients with Human Immunodeficiency Virus/Hepatitis C Virus Co-Infection in China

PLoS One. 2016 Sep 7;11(9):e0161844. doi: 10.1371/journal.pone.0161844. eCollection 2016.

Abstract

Background: Co-infection with hepatitis C virus (HCV) has become the most common cause of death in human immunodeficiency virus (HIV) infected patients on antiretroviral therapy. The distribution of HCV genotypes varies with geographical regions and time, and limited studies have focused on the HCV genotype in HIV/HCV co-infection.

Methods: The distribution of HCV genotypes was evaluated in 414 patients with HIV/HCV co-infection in three regions (South, Central and Northwest) of China from 2008 to 2010. The NS5B region of HCV was characterized using nested reverse transcription polymerase chain reaction. Nucleotide sequences obtained were subjected to phylogenetic analysis, and genotypes were assigned using published reference genotypes.

Results: Genotype 3 was the most prevalent HCV strain (36.2%), followed by genotype 6 (30.0%), genotype 1 (28.5%), genotype 2 (5.1%), and genotype 5 (0.2%). The distribution varied geographically. Genotype 6 (37.6%) was the predominant strain while genotype 1 (20.2%) was less common in the South compared to the Central and Northwest regions (all P < 0.001). The distribution also varied temporally. There was no significant difference in genotype distribution in Guangdong (a province in the South region), between patient cohorts from 2005-2008 and 2009-2010. However, outside Guangdong, genotypes 3 and 6a became significantly more prevalent (22.4% vs.42.2%, P< 0.001; 8.0% vs. 19.8%, P = 0.004), and genotype 1 less prevalent (54.4% vs.26.6%, P< 0.001) over time.

Conclusion: The most dramatic shift in genotypic distribution was the movement of HCV genotypes 3 and 6a outside of Guangdong in HIV/HCV co-infected patients. This movement appeared closely associated with transmission via injected drug use.

MeSH terms

  • Adult
  • China
  • Coinfection / epidemiology
  • Coinfection / genetics*
  • Coinfection / virology
  • Female
  • Genotype
  • HIV / genetics*
  • HIV / pathogenicity
  • HIV Infections / epidemiology
  • HIV Infections / genetics*
  • HIV Infections / virology
  • Hepacivirus / genetics*
  • Hepacivirus / pathogenicity
  • Humans
  • Male
  • Middle Aged
  • RNA, Viral / genetics

Substances

  • RNA, Viral

Grants and funding

This study was supported by grants from Chinese National Key Technologies R&D Program for the 12th Five-year Plan (2012ZX10001003-003), the Special Project to Benefit the People of Guangzhou Municipal Science and Technology Bureau (201300000092 and 2014Y2-00149) and National Natural Science Foundation of China (81201286). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.